Toumi Férial, Neunlist Michel, Denis Marc G, Oreshkova Tsvetelina, Laboisse Christian L, Galmiche Jean-Paul, Jarry Anne
INSERM U539, Faculté de Médecine, 1 rue Gaston Veil, 44035 Nantes Cedex 01, France.
Biochem Biophys Res Commun. 2004 Apr 23;317(1):187-91. doi: 10.1016/j.bbrc.2004.03.033.
Vasoactive intestinal peptide (VIP) has been shown to be a key regulator of intestinal epithelial functions such as mucus and chloride secretion, paracellular permeability, and cell proliferation. However, its regulatory role in intestinal epithelial chemokine production remains unknown. The aim of this study was (1) to determine whether VIP can modulate intestinal epithelial interleukin-8 (IL-8) production and (2) to identify intracellular mediators responsible for this effect. In the human colonic epithelial cell line HT29-Cl.16E, VIP stimulates IL-8 secretion dose-dependently and IL-8 mRNA level at 10(-9) M. The protein kinase A (PKA) inhibitor PKI did not abolish the effect of VIP. However, inhibition of the ERK1/2 and p38 MAPK pathways reduced the VIP-stimulated IL-8 secretion and mRNA level. Together, our results showed that VIP stimulates IL-8 production in intestinal epithelial cells via PKA-independent and MAPK-dependent pathways. These data suggest that VIPergic pathways can play an immunomodulatory role in intestinal epithelial cells, by regulating epithelial IL-8 secretion.
血管活性肠肽(VIP)已被证明是肠道上皮功能的关键调节因子,如黏液和氯离子分泌、细胞旁通透性以及细胞增殖。然而,其在肠道上皮趋化因子产生中的调节作用尚不清楚。本研究的目的是:(1)确定VIP是否能调节肠道上皮白细胞介素-8(IL-8)的产生;(2)确定负责此效应的细胞内介质。在人结肠上皮细胞系HT29-Cl.16E中,VIP以剂量依赖的方式刺激IL-8分泌,并在10(-9)M时刺激IL-8 mRNA水平。蛋白激酶A(PKA)抑制剂PKI并未消除VIP的作用。然而,抑制ERK1/2和p38丝裂原活化蛋白激酶(MAPK)途径可降低VIP刺激的IL-8分泌和mRNA水平。总之,我们的结果表明,VIP通过不依赖PKA和依赖MAPK的途径刺激肠道上皮细胞产生IL-8。这些数据表明,VIP能途径可通过调节上皮细胞IL-8分泌在肠道上皮细胞中发挥免疫调节作用。